SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-025227
Filing Date
2017-05-08
Accepted
2017-05-08 16:16:45
Documents
66
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v465353_10q.htm 10-Q 459433
2 EXHIBIT 10.1 v465353_ex10-1.htm EX-10.1 42375
3 EXHIBIT 10.2 v465353_ex10-2.htm EX-10.2 29385
4 EXHIBIT 31.1 v465353_ex31-1.htm EX-31.1 9929
5 EXHIBIT 31.2 v465353_ex31-2.htm EX-31.2 10179
6 EXHIBIT 32.1 v465353_ex32-1.htm EX-32.1 4097
7 EXHIBIT 32.2 v465353_ex32-2.htm EX-32.2 4026
  Complete submission text file 0001144204-17-025227.txt   4263694

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nvax-20170331.xml EX-101.INS 915143
9 XBRL TAXONOMY EXTENSION SCHEMA nvax-20170331.xsd EX-101.SCH 39192
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20170331_cal.xml EX-101.CAL 40116
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20170331_def.xml EX-101.DEF 267031
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20170331_lab.xml EX-101.LAB 347252
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20170331_pre.xml EX-101.PRE 305888
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 17822432
SIC: 2836 Biological Products, (No Diagnostic Substances)